Millennium Pharmaceuticals Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G)
14 Mai 2008 - 11:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF
TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE
ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-28494
Millennium Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
40 Landsdowne Street
Cambridge, Massachusetts 02139
(617) 679-7000
(Address, including zip code, and telephone number, including area
code, of registrants principal executive offices)
Common Stock, par value $0.001 per
share
Preferred Stock Purchase Rights
2.25% Convertible Senior Notes due November 15,
2011
(Title of each class of
securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to
terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)(i)
|
x
|
|
Rule 12h-3(b)(1)(i)
|
x
|
|
|
Rule 12g-4(a)(1)(ii)
|
o
|
|
Rule 12h-3(b)(1)(ii)
|
o
|
|
|
Rule 12g-4(a)(2)(i)
|
o
|
|
Rule 12h-3(b)(2)(i)
|
o
|
|
|
Rule 12g-4(a)(2)(ii)
|
o
|
|
Rule 12h-3(b)(2)(ii)
|
o
|
|
|
|
|
|
Rule 15d-6
|
o
|
|
Approximate number of
holders of record as of the certification or notice date:
Common Stock, par value
$0.001 per share 1 holder
Preferred Stock Purchase
Rights 0 holders
2.25% Convertible Senior
Notes due November 15, 2011 20 holders
Pursuant to the
requirements of the Securities Exchange Act of 1934, Millennium Pharmaceuticals, Inc.
has caused this Certification and Notice to be signed on its behalf by the
undersigned duly authorized person.
Date:
May 14, 2008
|
MILLENNIUM
PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Joel S.
Goldberg, Esq.
|
|
|
Name:
|
Joel S.
Goldberg, Esq.
|
|
|
Title:
|
Vice President and
Secretary
|
2
Millennium Pharmaceuticals (MM) (NASDAQ:MLNM)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Millennium Pharmaceuticals (MM) (NASDAQ:MLNM)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024